Portnoy Mark L. 4

4 · CRYO CELL INTERNATIONAL INC · Filed Jan 23, 2025

Form 4

Period: 2025-01-21

DirectorCo-CEO10% Owner

Transactions

Award
Stock Option
2025-01-21$8.08/sh+25,000$202,000→ 25,000 total
Exercise: $8.08From: 2025-01-21Exp: 2030-01-21→ Common Stock (25,000 underlying)

Holdings

Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (20,000 underlying)
20,000
Stock Option
Exercise: $6.47From: 2023-12-22Exp: 2028-12-22→ Common Stock (25,000 underlying)
25,000
Common Stock
(indirect: By 401(k))
42,266
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (100,000 underlying)
100,000
Common Stock
(indirect: By Partnership)
71,529
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common stock (22,222 underlying)
22,222
Stock Option
Exercise: $4.30From: 2022-12-23Exp: 2027-12-23→ Common Stock (25,000 underlying)
25,000
Common Stock
821,973
Stock Option
Exercise: $4.77From: 2023-01-03Exp: 2028-01-03→ Common Stock (25,000 underlying)
25,000

Footnotes (5)

[F1]Shares of common stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark Portnoy may be deemed beneficial owner as its general partner.
[F2]Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
[F3]8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
[F4]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
[F5]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.

Documents

1 file